Neurosense Therapeutics News - September 16, 2026
🔴 Neurosense Therapeutics is trading 14% down today following 1-for-20 reverse stock split
Neurosense Therapeutics is trading 14.01% down now at $6.04 after heightened volatility following its 1-for-20 reverse stock split, effective September 14,...
🔴 Neurosense Therapeutics is trading 6.4% down today after 1-for-20 reverse stock split
Neurosense Therapeutics is trading 6.4% down at $6.58 amid a broader biotech selloff. - The XBI is down 2.11% during the September 16, 2026 session; decline...
🟢 Neurosense Therapeutics is trading 5% up today after 1-for-20 reverse stock split
Neurosense Therapeutics is trading 5.26% up now at $7.40 following extreme volatility after its 1-for-20 reverse stock split, effective September 14, 2026. -...
🔴 Neurosense Therapeutics is trading 10.24% down in pre-market after its 1-for-20 reverse stock split
Neurosense Therapeutics is trading 10.24% down now at $6.31 after a highly volatile session following its 1-for-20 reverse stock split, effective September 14,...